Dr. Jeremy Rassen, co-founder of Aetion and current board director, will resume his leadership role as Aetion’s CEO
Dr. Christophe Berthoux brings international commercial and clinical research experience to Aetion as its new executive chair of the board
, /PRNewswire/ — Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced that it has confirmed the appointment of Jeremy Rassen, ScD, as chief executive officer (CEO) of Aetion. Dr. Rassen is a co-founder of the company and has been serving as interim CEO since June 2024. Additionally, Christophe Berthoux, DVM, former CEO of NAMSA, a contract research organization (CRO), joins Aetion as its new executive chair of the board, bringing a career of global healthcare leadership experience.
“Since co-founding the company in 2013, my goal has always been to ensure that Aetion creates the software to empower decision-makers across healthcare easily using deep scientific methods from causal …